Conclusion
CyberKnife® radiosurgery represents a conformal ablative radiation technique that offers a potent new treatment alternative for patients with primary or
recurrent bronchogenic carcinoma or pulmonary metastases. The advanced tracking capability of the CyberKnife® Synchrony® system enables radiation conformality around the tumor volume approaching
that of a surgeon’s scalpel. The treatment is safe to administer to patients that are not healthy enough to withstand definitive surgery, and offers a new option to patients with recurrent disease, who may have
previously had little if any additional effective treatment option available to them.